Exagen XGN
$ 2.47
-3.89%
Quarterly report 2024-Q2
added 08-05-2024
Country |
USA |
IPO year |
2019 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Fortunato Rocca |
Employees in the company |
153 |
Shares |
17.7 M |
Market Cap[1] |
$ 43.7 M |
EBITDA (LTM) |
$ -13.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.